(VEN) – June 11, a delegation of Trade and Economic Ministers from the Association of Southeast Asian Nations (ASEAN) toured Covidien’s state-of-the-art manufacturing and research and development facility in Irvine, California. Covidien is a leading global healthcare product company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Especially, Covidien manufactures neurovascular devices at the facility, which are used around the world as part of minimally-invasive surgical procedures to treat and save the lives of stroke victims. Organized by the US-ASEAN Business Council of Washington, D.C., the group is visiting several enterprises in the US. Covidien’s plant is the only healthcare manufacturing facility visited by the delegation during their weeklong trip. Harry de Wit, President, Asia, Covidien said, “We are honored that this delegation of senior Ministers from 10 markets in Asia chose to visit our facility to see first-hand the innovation and skill that goes into the production of these intricate medical devices. Several of the products manufactured at our facility are already used by neurointerventionalists in some markets in ASEAN. These products have the potential to limit or prevent the damage a stroke can have on the brain. Access to these products is a major shift in neurosurgery – it moves us from open surgery to minimally invasive techniques. I hope this visit will further open the door for these life-saving technologies in the Asian markets.” Bui Nga
Leave a Reply